Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup

Gastroenterology

Volumn 108, Issue 2, 1995, Pages 423-427

  Duerr, Richard H ^a   Neigut, Deborah A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE ANTIBODY; HLA DR2 ANTIGEN;

ALLELE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0028911445     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(95)90069-1     Document Type: Article

References (29)

1. Genetics of inflammatory bowel disease
2. The immunology of inflammatory bowel disease
3. Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis
4. HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis
5. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis
6. HLA-class II β-chain position 86: association with susceptibility to ulcerative colitis
7. HLA antigens in ulcerative colitis: a study in the Sicilian population
8. Distinct associations of HLA class II genes with inflammatory bowel disease
9. HLA antigens in inflammatory bowel disease
10. Ulcerative colitis—genetic features
11. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis
12. HLA DR4 is a marker for rapid progression in primary sclerosing cholangitis
13. HLA-D related antigens in inflammatory bowel disease
14. Ulcerative colitis and HLA phenotype
15. Nomenclature for factors of the HLA system, 1991
16. HLA class II nucleotide sequences, 1992
17. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease
18. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis
19. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses
20. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease
21. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis
22. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role
23. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique
24. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease
25. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: high prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis
26. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity
27. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers
28. Eleventh international histocompatibility workshop reference protocol for the HLA DNA-typing technique
29. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups